Anticonvulsants and specific analgesics for trigeminal neuralgia may work by inhibiting polysynaptic responses and blocking posttetanic potentiation; they can significantly reduce or eliminate the pain caused by stimulation of the infraorbital nerve in rats and cats, and reduce the thalamic potential, medullary and polysynaptic reflexes in cats, including the glossom-mandibular reflex.

Anticonvulsant effects have been demonstrated in some animal models of epilepsy; although epoxides are inferred to have clinical activity, their effect on the safety and efficacy of carbamazepine is unclear.

Carbamazepine is an anticonvulsant and specific analgesic for trigeminal neuralgia. It may work by inhibiting polysynaptic responses and blocking posttetanic potentiation, and can significantly reduce or eliminate pain caused by stimulation of the infraorbital nerve in rats and cats, and reduce thalamic potentials, medulla oblongata, and polysynaptic reflexes in cats, including the glossom-mandibular reflex.

Anticonvulsant effects have been demonstrated in some animal models of epilepsy; although the epoxide is inferred to have clinical activity, the impact of its activity on the safety and efficacy of carbamazepine is unclear.

Anticonvulsants and specific analgesics for trigeminal neuralgia may work by inhibiting polysynaptic responses and blocking posttetanic potentiation. They can significantly reduce or eliminate the pain caused by stimulation of the infraorbital nerve in rats and cats, and reduce the thalamic potential, medullary and polysynaptic reflexes in cats, including the glossom-mandibular reflex.

Anticonvulsant effects have been demonstrated in some animal models of epilepsy; although the epoxide is inferred to have clinical activity, the impact of its activity on the safety and efficacy of carbamazepine is unclear.

Anticonvulsants and specific analgesics for trigeminal neuralgia may work by inhibiting polysynaptic responses and blocking posttetanic potentiation; they can significantly reduce or eliminate the pain caused by stimulation of the infraorbital nerve in rats and cats, and reduce the thalamic potential, medullary and polysynaptic reflexes in cats, including the glossom-mandibular reflex.

It has shown anticonvulsant activity in some animal models of epilepsy, but the impact of its activity on the safety and efficacy of carbamazepine is unclear.

This product belongs to the macrolide antibiotics, which is the dodecyl sulfate of erythromycin propionate. It has antibacterial activity against Staphylococcus, various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can pass through the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. This product is only effective against bacteria with active division.